Insider Transactions in Q1 2021 at Amneal Pharmaceuticals, Inc. (AMRX)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 15
2021
|
Nikita Shah Executive Vice President |
SELL
Open market or private sale
|
Direct |
36,330
-14.63%
|
$217,980
$6.87 P/Share
|
Mar 15
2021
|
Nikita Shah Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
36,330
+12.77%
|
$72,660
$2.75 P/Share
|
Mar 15
2021
|
Joseph Todisco Executive Vice President |
SELL
Open market or private sale
|
Direct |
36,330
-11.49%
|
$217,980
$6.82 P/Share
|
Mar 15
2021
|
Joseph Todisco Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
36,330
+10.3%
|
$72,660
$2.75 P/Share
|
Mar 12
2021
|
Tasos Konidaris Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
87,719
+50.0%
|
-
|
Mar 01
2021
|
Andrew S Boyer Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,192
-4.5%
|
$30,960
$5.18 P/Share
|
Mar 01
2021
|
Andrew S Boyer Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
12,346
+8.23%
|
-
|
Mar 01
2021
|
Nikita Shah Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
3,607
-1.67%
|
$18,035
$5.18 P/Share
|
Mar 01
2021
|
Nikita Shah Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
11,729
+5.16%
|
-
|
Mar 01
2021
|
Joseph Todisco Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
3,906
-1.38%
|
$19,530
$5.18 P/Share
|
Mar 01
2021
|
Joseph Todisco Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
11,111
+3.77%
|
-
|
Feb 27
2021
|
Andrew S Boyer Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
16,301
-11.51%
|
$81,505
$5.39 P/Share
|
Feb 27
2021
|
Andrew S Boyer Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
31,662
+18.27%
|
-
|
Feb 27
2021
|
Stephen Manzano SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
5,796
-35.15%
|
$28,980
$5.39 P/Share
|
Feb 27
2021
|
Stephen Manzano SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
16,490
+50.0%
|
-
|
Feb 27
2021
|
Nikita Shah Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
11,548
-5.36%
|
$57,740
$5.39 P/Share
|
Feb 27
2021
|
Nikita Shah Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
35,620
+14.19%
|
-
|
Feb 27
2021
|
Joseph Todisco Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,972
-3.87%
|
$54,860
$5.39 P/Share
|
Feb 27
2021
|
Joseph Todisco Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
29,683
+9.47%
|
-
|